We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Poly(GP), neurofilament and grey matter deficits in <italic>C9orf72</italic> expansion carriers.
- Authors
Meeter, Lieke H. H.; Gendron, Tania F.; Sias, Ana C.; Jiskoot, Lize C.; Russo, Silvia P.; Donker Kaat, Laura; Papma, Janne M.; Panman, Jessica L.; van der Ende, Emma L.; Dopper, Elise G.; Franzen, Sanne; Graff, Caroline; Boxer, Adam L.; Rosen, Howard J.; Sanchez‐Valle, Raquel; Galimberti, Daniela; Pijnenburg, Yolande A. L.; Benussi, Luisa; Ghidoni, Roberta; Borroni, Barbara
- Abstract
Abstract: Objective: To evaluate poly(GP), a dipeptide repeat protein, and neurofilament light chain (NfL) as biomarkers in presymptomatic <italic>C9orf72</italic> repeat expansion carriers and patients with <italic>C9orf72‐</italic>associated frontotemporal dementia. Additionally, to investigate the relationship of poly(GP) with indicators of neurodegeneration as measured by NfL and grey matter volume. Methods: We measured poly(GP) and NfL levels in cerebrospinal fluid (CSF) from 25 presymptomatic <italic>C9orf72</italic> expansion carriers, 64 symptomatic expansion carriers with dementia, and 12 noncarriers. We explored associations with grey matter volumes using region of interest and voxel‐wise analyses. Results: Poly(GP) was present in <italic>C9orf72</italic> expansion carriers and absent in noncarriers (specificity 100%, sensitivity 97%). Presymptomatic carriers had lower poly(GP) levels than symptomatic carriers. NfL levels were higher in symptomatic carriers than in presymptomatic carriers and healthy noncarriers. NfL was highest in patients with concomitant motor neuron disease, and correlated with disease severity and survival. Associations between poly(GP) levels and small grey matter regions emerged but did not survive multiple comparison correction, while higher NfL levels were associated with atrophy in frontotemporoparietal cortices and the thalamus. Interpretation: This study of <italic>C9orf72</italic> expansion carriers reveals that: (1) poly(GP) levels discriminate presymptomatic and symptomatic expansion carriers from noncarriers, but are not associated with indicators of neurodegeneration; and (2) NfL levels are associated with grey matter atrophy, disease severity, and shorter survival. Together, poly(GP) and NfL show promise as complementary biomarkers for clinical trials for <italic>C9orf72‐</italic>associated frontotemporal dementia, with poly(GP) as a potential marker for target engagement and NfL as a marker of disease activity and progression.
- Subjects
CYTOPLASMIC filaments; GRAY matter (Nerve tissue); DIPEPTIDES; CEREBROSPINAL fluid; GENETIC carriers
- Publication
Annals of Clinical & Translational Neurology, 2018, Vol 5, Issue 5, p583
- ISSN
2328-9503
- Publication type
Article
- DOI
10.1002/acn3.559